Abstract
Currently, incorporating multiple therapeutic functions into one nanoplatform is attracting increasing attention for the development of efficient anticancer agents. Here, a novel core-shell-shell nanoparticle, which was synthesized to integrate imaging and photodynamic therapy (PDT) with photothermal therapy (PTT) and chemotherapy for enhanced antitumor efficiency, consists of upconversion (UC) core (NaYF4:Yb,Tm@NaYF4), Hypocrellin A (HA)/carbon dot (C-Dot) embodied silica sandwich shell, and mesoporous silica outer-shell. A photolabile o-nitrobenzyl derivative linker (NB linker) was prepared as the sensitive "gate" to encapsulate an anticancer drug (doxorubicin hydrochloride, DOX) in the mesopore. Upon 980 nm light irradiation, the UV-emission can induce the bond breaking of the NB linker as well as drug release. The visible emission can stimulate HA to generate singlet oxygen species (ROS); moreover the incorporated C-Dots also can absorb this light to evolve heat. In view of the excess expression of the lactobionic acid (LA) receptor on tumor cells, LA were grafted outside the nanocomposites to insure their specific targeting. The synergistic effect of NIR-triggered chemotherapy with PTT and PDT would be expected to reveal the enhanced cytotoxicity to cancer cells. And the novel UC and C/HA fluorescence also makes the nanocomposites a potential candidate for the imaging-guided multi-therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
